BCL2L1 antibody
-
- Target See all BCL2L1 Antibodies
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This BCL2L1 antibody is un-conjugated
-
Application
- Immunohistochemistry (IHC)
- Specificity
- BCL-XL (Ab-62) antibody detects endogenous levels of total BCL-XL protein.
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- This antiserum was produced against synthesized non-phosphopeptide derived from human BCL-XL around the phosphorylation site of serine 62 (A-D-SP-P-A).
- Top Product
- Discover our top product BCL2L1 Primary Antibody
-
-
- Application Notes
- WB: 1:500~1:1000.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 100ug/100ul.
- Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
-
-
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis." in: Science (New York, N.Y.), Vol. 275, Issue 5302, pp. 983-6, (1997) (PubMed).
: "X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death." in: Nature, Vol. 381, Issue 6580, pp. 335-41, (1996) (PubMed).
: "
-
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis." in: Science (New York, N.Y.), Vol. 275, Issue 5302, pp. 983-6, (1997) (PubMed).
-
- Target
- BCL2L1 (BCL2-Like 1 (BCL2L1))
- Alternative Name
- BCL-XL (BCL2L1 Products)
- Pathways
- Apoptosis, Negative Regulation of intrinsic apoptotic Signaling
-